TMCnet News

2018 Global Markets for Vaccine Technologies: Industry Environment, Strategies, Market Influences, and Driving Forces - ResearchAndMarkets.com

[March 20, 2018]

2018 Global Markets for Vaccine Technologies: Industry Environment, Strategies, Market Influences, and Driving Forces - ResearchAndMarkets.com

The "Global Markets for Vaccine Technologies" report has been added to ResearchAndMarkets.com's offering.

The report intends to explain the critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to the stakeholders and potential entrants.

This study contributes to the areas of market growth among vaccine manufacturers and end users. The report provides useful information to all the market players, potential entrants, government agencies and other interested parties.

Key Highlights

Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
A review of vaccine technology and its challenges, innovations, opportunities, and regulatory hurdles
Evaluations of market sizes and developments for vaccine classes (prophylactic and therapeutic), vaccine types (inactivated, conjugate, attenuated, recombinant vector, subunit, toxoid, combination, and dendritic cells), vaccine end users (humans and animals) and disease indications (infectious, cancer, and allergy)
Examination of the industry environment, strategies, market influences, and driving forces
Identification of regional market sizes, prices, and trends
Analysis of relevant patents
Company profiles of major key players in the market, including Abbott Laboratories., Baxter International Inc., Bayer Animal Health, GE Healthcare, Glaxosmithkline Plc, Johnson & Johnson, LG Life Sciences., Novartis Pharma Ag and Thermo Fisher Scientific

Key Topics Covered

1 Introduction